We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Investigators Clarify Issues With Draft Inspection Guidance
FDA Investigators Clarify Issues With Draft Inspection Guidance
November 1, 2013
FDA draft guidance on what constitutes delaying or denying an inspection continues to leave drugmakers concerned about how to interact with agency investigators on issues such as photos and records retrieval.